Tag: biomedical
-
Cancer Institute Spins-Off Company, Gains Licensing Deal
14 October 2015. Ontario Institute for Cancer Research is spinning off a new enterprise to discover therapies for blood-related cancers, and will partner with Janssen Biotech Inc. to take those therapies to market. The licensing deal between Novera Therapeutics Inc., the OICR spin-off company in Toronto, and Janssen Biotech, a division of Johnson & Johnson,…
-
Institute, GlaxoSmithKline ID Tuberculosis Candidates
13 October 2015. A biomedical research institute partnered with a lab backed by pharmaceutical company GlaxoSmithKline to identify candidates for drugs that act on bacteria causing tuberculosis. The team from Center for Infectious Disease Research in Seattle and Tres Cantos Open Lab Foundation, a lab in Spain sponsored by GlaxoSmithKline, published its findings in a…
-
Spin-Off to Provide Lower-Cost Molecular Imaging Technology
13 October 2015. A new enterprise based on research at Harvard University is offering a technology that allows ordinary microscopes to display high resolution images of single molecules. The company, Ultivue Inc., is founded by and licensing technologies from the lab of Peng Yin at Harvard’s Wyss Institute for Biologically Inspired Engineering. Yin and colleagues…
-
Study Shows Blood Test Finds Early Pancreatic Cancer
12 October 2015. An evaluation of a blood test to find early stages of pancreatic cancer showed the test successfully identified early-stage cancer in the vast majority of study participants with the disease. The findings published by a team from diagnostics company VolitionRx in Belgium and Lund University in Sweden appeared last week in the…
-
Chip Device in Development to Simulate Human Gut
9 October 2015. A team of medical researchers and engineers in North Carolina is developing a miniaturized device derived from human stem cells to better simulate the workings of a human gut. The five-year project is funded by $5.3 million grant from National Institute of Diabetes and Digestive and Kidney Diseases, part of National Institutes…
-
Harvard Spin-Off Commercializing Sepsis Treatment
9 October 2015. A new enterprise spun-off from Harvard University is developing a device for treating sepsis, a life-threatening infection often contracted in hospitals. The company, Opsonix Inc. in Boston, also raised $8 million in its first round of venture funding. Opsonix is licensing a technology for treating sepsis developed in Harvard’s Wyss Institute for…
-
Eli Lilly Expanding NYC Labs for Cancer Therapies
9 October 2015. The pharmaceutical company Eli Lilly and Company is expanding its research labs in New York City to boost discoveries of cancer therapies that harness the immune system. Lilly expects to hire 50 more research and support staff as part of the expansion. The company’s new facility will inhabit 30,000 square feet in…
-
MD Anderson, Biotech Form Antibody Discovery Company
7 October 2015. MD Anderson Cancer Center in Houston is partnering with the biotechnology company Theraclone Sciences to form a new enterprise devoted to discovering antibodies for cancer therapies harnessing the immune system. The company named OncoResponse, also based in Houston, attracted $9.5 million in its first venture funding round. OncoResponse plans to adapt Theraclone’s…
-
Breakout Labs Adds Four Science-Based Start-Ups
6 October 2015. Breakout Labs, an incubator of new enterprises based on discoveries from academic science labs, is adding four more companies to its portfolio. The new additions include companies developing advanced materials and sensors to measure food freshness, as well as discovering new therapies for diseases associated with the aging process. Breakout Labs is…
-
Partnership to Study Biomarkers in Liquid Biopsies
6 October 2015. DeNovo Sciences, a developer of liquid biopsies and analytics, is teaming with bioTheranostics, a cancer diagnostics company using molecular biomarkers, to test the feasibility of combining their technologies. Financial and intellectual property details of the collaboration were not disclosed. In testing for solid tumor cancers, such as lung or breast cancer, doctors…